Genflow Biosciences plc (LON:GENF – Get Free Report)’s stock price traded down 7.7% during mid-day trading on Thursday . The stock traded as low as GBX 1.80 and last traded at GBX 1.80. Approximately 320,415 shares were traded during mid-day trading, a decline of 85% from the average session volume of 2,163,648 shares. The stock had previously closed at GBX 1.95.
Genflow Biosciences Trading Up 13.9%
The stock has a 50 day simple moving average of GBX 2.02 and a 200-day simple moving average of GBX 2.05. The firm has a market capitalization of £11.61 million, a P/E ratio of -6.17 and a beta of 2.30.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
See Also
- Five stocks we like better than Genflow Biosciences
- Why These 3 Equal Weight ETFs Have Outperformed the S&P This Year
- MarketBeat Week in Review – 08/03 – 08/07
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
